Notable Labs Closes Merger Transaction With VBL Therapeutics
October 16, 2023 13:01 ET
|
Notable Labs
- Notable expects to initiate trading on the Nasdaq Capital Market under ticker symbol “NTBL” effective at market open on October 17 - - Aggregate net transaction proceeds expected to fund planned...
Notable Labs Presents Data Demonstrating PPMP’s Potential to Identify Novel Drug Combinations in JMML at the 2023 EHA Hybrid Congress
June 09, 2023 08:00 ET
|
Notable Labs
– Data demonstrates Notable’s PPMP potential in selecting more active investigational pre-hematopoietic stem cell therapy drug combinations, as compared to regimens currently used in JMML – FOSTER...
Notable Labs to Present Predictive Precision Medicine Platform (PPMP) Data in Juvenile Myelomonocytic Leukemia (JMML) at European Hematology Association (EHA) Hybrid Congress June 8 – 15, 2023
May 17, 2023 07:00 ET
|
Notable Labs
FOSTER CITY, Calif., May 17, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Inc. (“Notable”), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients,...
Notable Labs Presents Clinical Platform Validation Data at the 2023 American Association for Cancer Research Annual Meeting
April 18, 2023 09:00 ET
|
Notable Labs
- 100% accuracy predicting clinical responders with Notable’s PPMP with enhanced machine learning - - Fourth clinical validation study of Predictive Precision Medicine Platform - FOSTER CITY,...
Notable Labs to Present Results from Clinical Platform Validation Study at the 2023 American Association for Cancer Research (AACR) Annual Meeting
March 14, 2023 16:30 ET
|
Notable Labs
FOSTER CITY, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Inc. (“Notable”), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients,...
Notable to Host July 23 Webinar with Stanford Cancer Institute and MDS Foundation: Emerging Treatment Approaches for Higher Risk Myelodysplastic Syndromes
July 13, 2020 11:00 ET
|
Notable Labs
FOSTER CITY, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today...
Notable Appoints Biotech Veteran Joseph Wagner PhD as Chief Scientific Officer
July 08, 2020 11:00 ET
|
Notable Labs
FOSTER CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today...
Stanford study finds that Notable’s drug sensitivity screening platform can identify potentially useful drugs for MDS patients refractory to standard therapies
June 23, 2020 11:00 ET
|
Notable Labs
FOSTER CITY, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today...
Notable and MDS Foundation Announce Partnership to Collaborate on Clinical MDS Trials and Advance Drug Therapies for MDS Patients
April 30, 2020 11:00 ET
|
Notable Labs
FOSTER CITY, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with its scientific technology platform to rapidly advance drug development, announced a...
Notable Announces Leadership Team Expansion
April 09, 2020 14:03 ET
|
Notable Labs
SAN FRANCISCO, April 09, 2020 (GLOBE NEWSWIRE) -- Notable, a technology leader redefining cancer treatment through rapid drug development via a clinically validated platform, announced today its...